Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03838445 · ClinicalTrials.gov registry record · NA
Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)
A NA study of Pulmonary Arterial Hypertension, sponsored by V-Wave.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 5
- Study locations
NCT03838445: Recruiting NA study of Pulmonary Arterial Hypertension, sponsored by V-Wave.
NCT03838445 is a NA study of Pulmonary Arterial Hypertension that is actively recruiting participants, run by V-Wave. The registered enrollment target is 20 participants, below the 462-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (96% lower). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03838445, a NA study of Pulmonary Arterial Hypertension, is actively recruiting participants, sponsored by V-Wave.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objectives of the RELIEVE-PAH study are to obtain first-in-human experience with the study device in patients with severe pulmonary arterial hypertension, including evidence of initial safety, device performance and possible signals of clinical effectiveness.
Primary Outcome
Percentage of Treatment group patients experiencing any device-related Major Adverse Cardiovascular or Neurological Events (MACNE) during the first 90-days after implantation
Conditions Studied
Interventions
- DEVICE V-Wave Interatrial Shunt
Study Locations (5)
California
- Keck Medical Center of USC - Los Angeles
- University of California, San Francisco - San Francisco
Other
- Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval - Québec
- Instituto Nacional de Cardiologia - Mexico City
Ohio
- The Ohio State University Wexner Medical Center - Davis Heart & Lung Research Institute - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-02-14 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT03838445 shows while recruiting
NCT03838445 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 462-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Pulmonary Arterial Hypertension appearing as the primary indexed condition, and to 1 intervention - of which V-Wave Interatrial Shunt is the first listed.
NCT03838445 lists 5 locations in 3 states (California, Other, Ohio).
Frequently Asked Questions
What is clinical trial NCT03838445 about?
NCT03838445 is a clinical study titled "Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)". The objectives of the RELIEVE-PAH study are to obtain first-in-human experience with the study device in patients with severe pulmonary arterial hypertension, including evidence of initial safety, device performance and possible signals of clinical effectiveness.
What is the current status of trial NCT03838445?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2020-02-14. Estimated completion is 2026-12-31.
What conditions does trial NCT03838445 study?
This clinical trial studies the following conditions: Pulmonary Arterial Hypertension.
What interventions are being tested in trial NCT03838445?
The interventions under investigation include: V-Wave Interatrial Shunt (DEVICE).
Who is sponsoring clinical trial NCT03838445?
This trial is sponsored by V-Wave, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03838445 being conducted?
This trial has 5 study locations across California, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Arterial Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03838445's enrollment target sits among peer trials
20 49th of 63 higher than 10 of 63 other Pulmonary Arterial Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Arterial Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
RECRUITING · NA
-
Mobile Health Intervention to Improve Exercise in Pediatric PH
RECRUITING · NA
-
A Study of Pulmonary Hypertension Peripheral Limitations
RECRUITING · NA
-
Safety and Impact of Low Resistance Exercise Training on Quality of Life in Pulmonary Arterial Hypertension
ACTIVE NOT RECRUITING · NA
-
Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI